Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: The FDA approved a new simplified monthly dosing schedule for Johnson & Johnson’s Rybrevant Faspro (amivantamab and hyaluronidase-lpuj). Options analysis identified 15 unusual trades suggesting financial giants placed a sizeable bearish bet on Johnson & Johnson.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.